Alle Studien
RekrutierungTherapeutische Anwendung (Phase IV)Interventionell

ABATACEPT VERSUS TOCILIZUMAB BY SUBCUTANEOUS ADMINISTRATION FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN TARGETED TREATMENT INADEQUATE RESPONDER PATIENTS: A RANDOMIZED, OPENLABELED, SUPERIORITY TRIAL. -SUNSTAR-

This research study, called SUNSTAR, is for adults living with rheumatoid arthritis who haven't found enough relief from one or two other targeted treatments. We are comparing two medicines, Orencia (abatacept) and RoActemra (tocilizumab), which are both given as injections. The main goal is to see which medicine is better at reducing the signs and symptoms of rheumatoid arthritis after six months. We'll be looking at things like how many joints are tender or swollen, and how patients feel overall. We also want to understand more about how these medicines work and any side effects they might cause over 12 months.

Auf einen Blick

Status
Rekrutierung
Phase
Therapeutische Anwendung (Phase IV)
Sponsor
Groupement Des Hopitaux De L'Institut Catholique De Lille
Einschreibeziel
224
Starten
31. Juli 2024

Worum geht es in dieser Studie?

You might have heard of this research study called SUNSTAR. It's looking into two medicines, Orencia and RoActemra, that are used to treat rheumatoid arthritis. These medicines are given by injection, and they typically help to calm down the overactive immune system that causes the condition. The study is specifically designed for people who have already tried one or two other modern treatments for their rheumatoid arthritis, often called 'targeted treatments', but haven't found them effective enough to control their symptoms.

The main aim of this study is to compare how well Orencia and RoActemra work. Doctors will be checking to see which medicine helps to reduce the symptoms of rheumatoid arthritis, such as joint pain and swelling, more effectively over a period of six months. They'll use a special score, called the Clinical Disease Activity Index (CDAI), which looks at how many joints are tender or swollen, and how you and your doctor feel your disease is doing overall. This helps them get a clear picture of how much your rheumatoid arthritis is improving.

Beyond the first six months, the study will continue to follow people for a full year. This allows researchers to see how well the treatments continue to work over time, explore other ways the treatments might help (like improving quality of life), and carefully record any side effects. By doing this, the study hopes to provide valuable information to doctors and patients about the best ways to manage rheumatoid arthritis when initial treatments haven't been fully successful.

Wichtige Erkenntnisse

  • The study compares two licensed medicines for rheumatoid arthritis: Orencia and RoActemra.
  • It's for adults whose current treatments for rheumatoid arthritis aren't working well enough.
  • The main goal is to see which medicine best reduces rheumatoid arthritis symptoms over 6 months.
  • Participation involves regular clinic visits, injections, and health checks over a year.
  • It helps doctors understand more about these treatments and their effects.
  • Sie können die Teilnahme jederzeit beenden.

Wer könnte berechtigt sein?

This study is looking for adult volunteers, aged 18 or over. This means anyone from 18 years old upwards can be considered.

To be eligible, you must have been diagnosed with rheumatoid arthritis. Importantly, your rheumatoid arthritis should not be well-controlled by the one or two targeted treatments you might have tried already. This study is specifically for people where their current or previous treatments haven't been effective enough.

Both men and women can take part in this research. There will be other specific medical checks to make sure the study is a good fit for your health situation, so it's important to discuss this with your doctor.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Sind Sie 18 Jahre alt oder älter?
  2. Do you have a diagnosis of rheumatoid arthritis?
  3. Has your rheumatoid arthritis not improved enough with other modern treatments?
  4. Are you happy to have regular injections and clinic visits for 12 months?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If you decide to take part in this study, you will receive either Orencia or RoActemra, both given as an injection using a pre-filled syringe. You'll have regular appointments over 12 months where doctors will assess your rheumatoid arthritis. During these visits, the medical team will check your joints for tenderness and swelling, ask you questions about how you feel, and likely complete questionnaires about your quality of life. They will also take blood samples to monitor your overall health and how the treatment is affecting you. There will also be some imaging tests, like ultrasounds of your joints and X-rays of your hands, wrists, and feet, at certain points. The total duration of active participation in the study will be 12 months.

Potenzielle Risiken und Vorteile

Taking part in this study may offer potential benefits, such as receiving close medical attention and access to a supervised treatment that could improve your rheumatoid arthritis symptoms. However, like all medicines, Orencia and RoActemra can have side effects, which the study will carefully monitor. You might experience common side effects, or in some cases, more serious ones. You are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Standorte (1)

Einige Standortangaben sind ungefähr. Wir arbeiten daran, dies zu verbessern — bitte überprüfen Sie die Angaben mit dem Versuchsteam, bevor Sie reisen.
  • —
    Unbestätigt
    Frankreich

Häufige Fragen

Was ist rheumatoide Arthritis?

Rheumatoid arthritis is a long-term condition where your immune system mistakenly attacks healthy cells in your joints, leading to pain, swelling, and stiffness.

What does 'targeted treatment' mean?

Targeted treatments are medicines designed to home in on specific parts of the immune system that cause inflammation in rheumatoid arthritis, often working differently from older medications.

What is a 'pre-filled syringe'?

A pre-filled syringe is a ready-to-use injection device that contains a single dose of medicine, making it easier and safer to administer.

Werde ich wissen, welches Medikament ich bekomme?

This is an 'open-label' study, which means both you and your doctor will know whether you are receiving Orencia or RoActemra.

What happens if the medicine doesn't work for me?

The study will closely monitor your condition, and if the treatment isn't controlling your rheumatoid arthritis well enough, your doctor will discuss other options with you.

Wie Sie mehr erfahren können

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "ABATACEPT VERSUS TOCILIZUMAB BY SUBCUTANEOUS ADMINISTRATION … wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.